The challenges of the COVID-19 Vaccine global distribution: Analysis of the demanding logistics needs and sourcing expectations

We continue to see immense efforts going into the development of Covid-19 vaccines by numerous Pharmaceutical companies across the globe. Vaccines typically require years of research and testing before reaching the patient, but in 2020, scientists embarked on a race to produce safe and effective Covid-19 vaccines in record time. Researchers are currently testing 64 vaccines in clinical trials on humans, and 20 have reached the final stages of testing. Two vaccines are approved for full use and eight have been approved for limited/emergency use in the immunization against Covid-19. While this development has been great, the world cannot wait for more vaccines to be available and easily accessible for administration.